Diseases [C] » Nutritional and Metabolic Diseases [C18] » Nutrition Disorders » Malnutrition
Description
An imbalanced nutritional status resulting from insufficient intake of nutrients to meet normal physiological requirement. MeSH
Hierarchy View
Subtype Terms (5)
Deficiency Diseases
177 drugs (102 approved, 75 experimental)
Fetal Nutrition Disorders
1 experimental drug
Refeeding Syndrome
1 experimental drug
Severe Acute Malnutrition
24 drugs (17 approved, 7 experimental)
Starvation
4 drugs (3 approved, 1 experimental)
Approved Indicated Drugs (34)
Phase 4 Indicated Drugs (28)
Phase 3 Indicated Drugs (20)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (38)
Organization Involved with Phase 4 Indications (54)
Addis Continental Institute of Public Health
Amhara Public Health Institute
Asociación Civil Selva Amazónica
Bill and Melinda Gates Foundation
Centre de Recherche et Interventions en Sante Publique (CRISP)
Centro Medico Lic Adolfo Lopez Mate
Chinese University of Hong Kong
Institut et Haute école de la Santé, La Source
Kenya Medical Research Institute
Medical University of South Carolina
National Cheng Kung University
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Child Health and Human Development (NICHD)
National Institute of Mental Health (NIMH)
Organization Involved with Phase 3 Indications (63)
Bangladesh Rural Advancement Committee
Centre de Recherches Médicales et Sanitaires, Niger
Chinese Academy of Medical Sciences
Coast General Hospital, Mombasa, Kenya
International Atomic Energy Agency
International Center for Diarrheal Disease Research
Jiangxi Provincial Cancer Hospital
King George's Medical University
Kintampo Health Research Centre, Ghana
Los Angeles Biomedical Research Institute
Mbale Regional Referral Hospital
Queen Elizabeth Central Hospital, Blantyre, Malawi
Uni Health, Uni Research, Norway
Organization Involved with Phase 2 Indications (16)
Organization Involved with Phase 1 Indications (84)
Daewon Pharmaceutical Co., Ltd.
Daewoong Pharmaceutical Co. LTD.
Farmagen Ar-Ge Biyot. Ltd. Sti
FARMOVS Clinical Research Organisation
Kremers Urban Development Company
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Novagenix Bioanalytical Drug R&D Center
Novum Pharmaceutical Research Services
Pharmactive İlaç San.ve Tic.A.S
PharmaKinetics Laboratories Inc.
Organization Involved with Other Experimental Indications (74)
Academy for Educational Development
Bangabandhu Sheikh Mujib Medical University
Bio-Kinetic Clinical Applications
Centre for Research in Environmental Epidemiology, Spain
Community Health Center of Franklin County
Herbert Irving Comprehensive Cancer Center
Jawaharlal Institute of Postgraduate Medical Education and Research
Malaria Research and Training Center, Bamako, Mali
Mysore Medical College and Research Institute
National Center for Complementary and Integrative Health (NCCIH)
National University of Ireland
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Sitaram Bhartia Institute of Science and Research
The Children's Investment Fund Foundation
The Mathile Institute for the Advancement of Human Nutrition
United States Department of Agriculture
Universidad Autonoma de Queretaro
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
